From Dr. Bredesen
Chief Science Officer
March 18, 2026•From Dr. Bredesen, News
Artificial intelligence is transforming modern life, but its limitations are becoming just as clear as its potential. In this blog, Dr. Dale Bredesen contrasts AI with evolutionary intelligence (EI), explaining how an evolution-based approach to health is driving unprecedented improvements in cognition, biomarkers, and chronic disease outcomes. Read More »
February 23, 2026•From Dr. Bredesen, News
When does Alzheimer’s truly begin — when symptoms appear, or decades earlier when pathology first develops? In this blog, Dr. Bredesen explores the growing controversy over diagnosis, biomarker testing, and prevention — and why the answer could determine whether we wait for decline or act in time to prevent it. Read More »
January 16, 2026•From Dr. Bredesen, News
Archimedes and Alzheimer: A Place to Stand
Archimedes said a lever and a place to stand could move the world. In Alzheimer’s, we finally have both. The Evanthea randomized controlled trial shows statistically and clinically meaningful cognitive improvements, without the risks seen in drug trials. Dr. Bredesen explains why Evanthea creates a foundation for what comes next. Read More »
December 15, 2025•From Dr. Bredesen, News
Solving Four of the World’s Health Problems
In his blog, Solving Four of the World’s Most Serious Health Problems, Dr. Bredesen describes new breakthroughs in Alzheimer’s, cancer, pandemics, and antibiotic resistance — four of the most pressing global health needs today. It is a time of great medical advances, and these are just four of the many examples of progress. Read More »
November 18, 2025•From Dr. Bredesen, News
In Dr. Bredesen’s blog, Here’s to TW3!, he describes the many advances that have occurred in 2025, from the results of the Evanthea randomized controlled clinical trial to the first successes in atypical presentations of Alzheimer’s to the institution of the ReCODE protocol in The Vineyards and other assisted living facilities, as well as other exciting progress. Read More »
October 17, 2025•From Dr. Bredesen, News
What We Are Learning From the Randomized Controlled Clinical Trial
In Dr. Bredesen’s October blog, he describes the initial conclusions from the Evanthea randomized controlled clinical trial, a trial that will be completed on October 31. While there is still extensive data to process, some surprising findings have emerged even at this early stage, and he details these in the blog. Read More »
September 18, 2025•From Dr. Bredesen, News
Sacrificing Patients in the Name of Healthcare
In his latest blog, Sacrificing Patients in the Name of Healthcare, Dr. Dale Bredesen highlights how healthcare misinformation often comes from outdated medical norms rather than patients. He calls for a paradigm shift, away from profit-driven treatments and toward prevention, early detection, and functional approaches that restore health. Read More »
August 14, 2025•From Dr. Bredesen, News
In his blog, Dr. Bredesen reflects on the corruption, hypocrisy, and profit-driven motives dominating Alzheimer’s research. He contrasts costly, ineffective drugs with proven multi-modal approaches, warning of ongoing misinformation and division — yet remains hopeful that pioneers will drive effective prevention and treatment forward. Read More »